Jun-kyu Hwang | Neurosurgery | Best Researcher Award

Prof. Jun-kyu Hwang | Neurosurgery | Best Researcher Award

Dr. Jun Kyu Hwang is a Clinical Assistant Professor in the Department of Neurosurgery at Yongin Severance Hospital, affiliated with Yonsei University College of Medicine in Korea. He earned his M.D. from Yonsei University in 2010 and later pursued a Master’s and currently a Ph.D. in Neurosurgery at the same institution. With extensive clinical training and fellowships in pediatric and general neurosurgery at prestigious institutions including Severance Hospital and Asan Medical Center, Dr. Hwang has built a robust academic and clinical foundation. Since 2021, he has been serving in his current role, contributing to surgical education, clinical practice, and neurosurgical research. His work spans advanced neurosurgical procedures, clinical innovation, and academic mentorship. He is known for his dedication to patient care, surgical precision, and academic rigor. Dr. Hwang’s career reflects his commitment to advancing neurosurgical practice through a combination of hands-on experience and continued academic pursuit.

Profile

🎓 Education

Dr. Hwang completed his M.D. degree at Yonsei University College of Medicine in 2010, laying the groundwork for a career dedicated to neuroscience and clinical surgery. Driven by academic excellence and a passion for neurosurgery, he further obtained a Master’s degree in Neurosurgery from the Graduate School of Yonsei University between 2016 and 2019. His postgraduate educational journey reflects a focus on deepening his expertise in surgical techniques, neurological pathology, and clinical outcomes. Continuing this academic momentum, he is currently pursuing a Ph.D. in Neurosurgery at Yonsei University. This doctoral work demonstrates his strong interest in neurosurgical innovation and research, with a commitment to integrating scientific advancement into clinical practice. His education spans both rigorous academic study and immersive clinical training, forming a comprehensive foundation for excellence in neurosurgical care and research. Dr. Hwang’s ongoing academic endeavors ensure that he remains at the forefront of modern neurosurgical developments.

🧪 Experience

Dr. Hwang began his clinical journey with a neurosurgical residency at Severance Hospital, Yonsei University from 2014 to 2017, where he gained comprehensive surgical and clinical experience. He continued his training as a Clinical Fellow in Pediatric Neurosurgery at Severance Hospital in 2018, focusing on the surgical treatment of neurological conditions in children. From 2019 to 2020, he expanded his expertise through a fellowship at Asan Medical Center under the University of Ulsan, specializing further in complex neurosurgical procedures. In 2021, he assumed the role of Clinical Assistant Professor in the Department of Neurosurgery at Yongin Severance Hospital, Yonsei University. His professional roles have encompassed patient care, surgical instruction, and clinical mentorship. Dr. Hwang’s experience reflects a trajectory of increasing responsibility, technical refinement, and dedication to both adult and pediatric neurosurgical practice. He continues to contribute significantly to clinical excellence, resident education, and research development in neurosurgery.

🏅 Awards and Honors

While specific awards and honors are not listed in the provided CV, Dr. Jun Kyu Hwang’s prestigious appointments and continuous academic advancement signify professional recognition and trust by leading medical institutions. His acceptance into competitive fellowships at Severance Hospital and Asan Medical Center—two of Korea’s top medical centers—reflect his exceptional competence and commitment to excellence. His transition from residency to fellowship and then to Clinical Assistant Professor at Yongin Severance Hospital is itself a mark of distinction. Typically, such roles are conferred upon individuals who demonstrate not only strong clinical capabilities but also promise in academic and research contributions. His ongoing Ph.D. candidacy at Yonsei University also indicates academic recognition and support for his scholarly potential. These milestones together point to a career distinguished by merit-based progression, institutional confidence, and high standards of patient care and medical professionalism.

🔬 Research Focus

Dr. Hwang’s research focuses on the clinical and surgical aspects of neurosurgery, with a particular interest in pediatric neurosurgery, advanced surgical techniques, and neuro-oncology. His academic pathway, including a Master’s and ongoing Ph.D. in Neurosurgery, is aligned with investigating surgical outcomes, improving procedural methodologies, and exploring innovative approaches to treating neurological disorders. His clinical fellowships and continued academic pursuits suggest involvement in translational research—bridging laboratory findings with clinical applications. As a Clinical Assistant Professor, he likely collaborates in institutional research initiatives, contributes to clinical trials, and mentors junior researchers. His research aims to enhance precision in neurosurgical interventions, reduce complications, and improve recovery outcomes, particularly in pediatric populations. With experience in high-volume tertiary hospitals, Dr. Hwang integrates his research with real-world patient care, contributing data-driven insights to the academic community. His long-term vision likely involves developing safer, more effective neurosurgical strategies through evidence-based practice.

Conclusion

Dr. Jun Kyu Hwang exemplifies a dedicated neurosurgeon committed to academic excellence, clinical expertise, and research innovation, making impactful contributions to both patient care and the neurosurgical field in Korea.

Parisa Shamsesfandabadi | Radiation oncology | Best Researcher Award

Dr. Parisa Shamsesfandabadi | Radiation oncology | Best Researcher Award

Dr. Parisa Shamsesfandabadi 🇺🇸 is a passionate radiation oncologist with a dynamic academic and clinical background, currently serving as Chief Resident at Allegheny Health Network in Pittsburgh, PA 💼. She combines a global medical foundation from Iran with extensive U.S. clinical training 🇮🇷➡️🇺🇸. Driven by innovation and compassion, Parisa has earned national recognition with multiple prestigious awards 🏅. Her dedication extends beyond clinical excellence to impactful research, global health, and mentorship 🌍📚. With hands-on experiences at leading institutions like Duke, UNC, and VA Medical Center, her expertise spans brain, breast, liver, and prostate cancer research 🧠💪. Parisa’s unique blend of research, service, and leadership reflects her lifelong commitment to patient care, academic excellence, and transformative cancer therapy 🌟. In addition to her clinical role, she actively contributes as an editorial assistant, social ambassador, and peer-reviewer to renowned medical journals and organizations 📖🤝. She’s a true rising star in oncology 🚀.

Profile

Education 🎓

📍 Chief Resident, Radiation Oncology – Allegheny Health Network, PA (2024–Present) 👩‍⚕️
📍 Residency, Radiation Oncology – Allegheny Health Network, PA (2019–2024) 💉
📍 Internship (PGY-1), Transitional Year – Southern Hills Hospital, Las Vegas, NV (2019–2020) 🏥
📍 M.D. – Kashan University of Medical Sciences, Iran (2007–2014) 🎓🇮🇷
📍 High School – Tehran Farzanegan School, NODET (2000–2007) 🧠🏫
Parisa’s academic journey reflects brilliance from the start, attending Iran’s elite NODET school 🌟. She pursued medicine at KaUMS, consistently ranking top in medical Olympiads 🥇. Her U.S. medical training includes internship and residency in highly reputed institutions, leading to her current leadership as Chief Resident 🧑‍⚕️. Her academic record is peppered with awards, research, and international training, preparing her for a successful future as a physician-scientist and leader in cancer care 🧬🩺.

Experience 👨‍🏫

📍 Chief Resident, Radiation Oncology – AHN (2024–Present)
📍 Research Associate – VA Medical Center, Durham, NC 🧪
📍 Visiting Scholar – Duke, UNC, CCC Las Vegas 🏫
📍 Research Visitor – RAI Lab, Duke University (Glioma Imaging) 🧠
📍 Research Associate – KaUMS, Iran (Probiotics Study) 🧃
📍 Medical Assistant – Advanced Pain Management, NV 💊
📍 Volunteer – Rural Clinics, Pediatrics & Geriatrics Programs 🧒👵
📍 Editorial Assistant – eContour 📘
📍 Communications Intern – RTOG Foundation 💬
Dr. Parisa brings a rich portfolio of clinical and research experience across top U.S. and international institutions 🌍. From clinical research on prostate and brain cancers to hands-on patient care and administrative duties, she is known for her leadership, empathy, and academic dedication 🏥🧠📊.

Awards & Recognitions 🏅

🎖 2024 RTOG Communications Intern
💰 2023 $25K Grant – MRLinac Sarcoma (Benedum Foundation)
🧳 2023 Travel Grants – ARS, ACRO, ACR
🥇 2022 Resident Best Abstract – ABS
🎖 2022 Editorial/Fellow Roles – eContour, The Mednet, NRG
🌟 2022 RePRT Peer Reviewer – Red Journal
🏆 2022 Travel Award – eContour Vulvar Cancer Guidelines
👩‍🎓 Olympiad Champion – 4x Gold in Iran Medical Olympiads
🧠 UNESCO Youth Award – Earthquake Awareness Project
🏅 Sharif University Medal – Math & Graphs Competition
🧪 Ranked 1st in Nationwide Chemistry Lab Exam
📕 Published Short Book – “World of Animals”
📚 Parisa’s excellence is recognized through national and international grants, editorial roles, peer-review selections, and top medical student honors 🏅. From early academic brilliance to clinical and research impact, her accolades reflect a rare blend of intellect, service, and innovation 🌍✨.

Research Interests 🔬

🧠 Radiogenomics – Brain Cancer Imaging (Duke, UNC)
🧬 MR-Linac SBRT – Liver, Pancreatic, Prostate, and Breast Cancers
💪 Strength Training Impact – Radiotherapy in Breast Cancer
🧲 Adaptive Radiation Therapy – CBCT, MRI-based Comparisons
🔍 Treatment Planning – Monte Carlo vs Cone Algorithm
🧫 Biomarker Evaluation – Breast Cancer (KaUMS & Leiden University)
🧃 Probiotics vs Regular Yogurt in Pediatric Diarrhea
🖥 Editorial & Peer Review Roles – Red Journal, The Mednet, eContour
Dr. Shamsesfandabadi’s research bridges advanced imaging, functional planning, and personalized therapy in oncology 🧠. Her projects focus on enhancing precision radiation therapy using radiogenomics, AI-driven adaptive planning, and improving survivorship through integrative approaches 💻💡. She’s driven to optimize outcomes in patients with complex cancers like gliomas, HCC, and pancreatic malignancies, while actively contributing to guidelines and clinical trials 🧪💥. A rising voice in the next-gen of physician-scientists 🌟.

Publications 
  • -Kirichenko, A., Uemura, T., Hasan, S., Lian, Y., Abel, S., Renz, P.,
    Shamsesfandabadi, P., Carpenter, J., Thai, N., “Stereotactic Body Radiotherapy
    (SBRT) for Hepatocellular Carcinoma (HCC) with Single Photon Emission
    Computed Tomography (SPECT) Functional Treatment Planning in Patients with
    Advanced Hepatic Cirrhosis.” Advances in Radiation Oncology (Accepted,
    July 2023).
  • Goss, M., Champ, C., Trombetta, M, Shamsesfandabadi, P., DeMartino, V.,
    Wegner, R., Beriwal, S., Eisen, V. “The Comparison of Collapsed Cone and
    Monte Carlo Algorithms in Tangential Breast Planning.” Journal of Radiotherapy
    in Practice. (April 2023).
  • Mazurowski, M.A., Clark, K., Czarnek, N. M., Shamsesfandabadi, P., et al.
    “Radiogenomics of lower-grade glioma: algorithmically assessed tumor shape
    is associated with tumor genomic subtypes in a multi-institutional study with
    The Cancer Genome Atlas data.” Journal of Neuro-Oncology. 2017, May;
    133(1): 27-35. Cited in PubMed; PMID: 28470431.
  • Mazurowski, M. A., Clark, K., Czarnek, N. M., Shamsesfandabadi, P., et al.
    (2017, March 21). “Radiogenomic analysis of lower grade glioma: a pilot multiinstitutional study shows an association between quantitative image features
    and tumor genomics.” SPIE, The international society for optics and photonics.
  • – Sharif, A., Kheirkhah, D., Shamsesfandabadi, P., et al. “Comparison of Regular
    and Probiotic Yogurts in Treatment of Acute Watery Diarrhea in Children.”
    Journal of Probiotics and Health. 2016, Feb; 5(1): 164.

Pedram Fadavi | Radiation oncology | Best Researcher Award

Dr. Pedram Fadavi | Radiation oncology | Best Researcher Award

Dr. Pedram Fadavi, M.D., is a distinguished radiation oncologist and associate professor at Iran University of Medical Sciences (IUMS). Born in Tehran, Iran (1974), he specializes in cancer treatment, radiotherapy, and oncological research. With over two decades of experience, he has contributed extensively to academia and clinical practice. His expertise spans breast, head, neck, and gynecologic cancers. He has published influential research in radiomics, chemotherapy delays, and treatment-induced complications. A dedicated educator, he mentors medical students and residents while advancing oncology research. 📚💡

Profile

Education 🎓

Dr. Fadavi earned his M.D. (2000) and board certification in Radiation Oncology (2006) from Shahid Beheshti University, Tehran. He completed a seven-year medical program (1993-2000) and specialized in radiation oncology during his residency (2002-2006). He holds an Iran Medical Council license (No. 76602) and actively contributes to medical education and research at IUMS. His training provided a strong foundation in oncologic treatments and innovative radiotherapy techniques. 🔬📖

Experience 👨‍🏫

Since 2006, Dr. Fadavi has served as a radiation oncologist at Haftome Tir Hospital (IUMS). He became an associate professor in 2008, teaching at IUMS and Tehran University of Medical Sciences (2011-2013). His clinical expertise includes radiotherapy advancements, cancer management, and interdisciplinary oncology research. He has led multiple projects addressing radiation-induced complications and patient outcomes. His leadership in academic and clinical oncology has shaped the future of radiation therapy in Iran. 🌍🔬

Research Interests 🔬

Dr. Fadavi’s research centers on radiomics, predictive modeling, and improving radiotherapy outcomes. His recent studies explore machine learning applications in radiation toxicity prediction, chemotherapy delays, and novel treatment strategies for breast, cervical, and head-and-neck cancers. He investigates biomarkers for cancer prognosis and response to therapy, with a strong emphasis on precision oncology. His work in computational oncology and artificial intelligence-driven diagnostics is shaping the future of personalized cancer treatment. 💻🧬Awards & Recognitions 🏅

Dr. Fadavi has received numerous accolades for his contributions to radiation oncology and medical research. His work on radiomics, treatment toxicity, and innovative oncological therapies has been recognized in national and international forums. His publications in leading journals and collaborations with top researchers underscore his impact on global cancer research. He has also been honored for his excellence in medical education, research innovation, and commitment to improving patient care. 📜🏅

Publications 📚

Dr Alexander Chernov| neuro-oncology | Best Researcher Award

Dr Alexander Chernov| neuro-oncology | Best Researcher Award 🏆


DR at Institute of Experimental Medicine🎓

Dr. Alexander Nikolaevich Chernov is a PhD and Senior Researcher at the World-Class Research Centre “Center for Personalized Medicine” at the Institute of Experimental Medicine, Saint Petersburg, Russia 🧬. With an impressive portfolio of over 80 scientific papers, six patents, and ongoing collaborations with international institutions, Dr. Chernov has made significant contributions in the fields of neuroimmunooncology, glioblastoma research, and the study of nerve growth factors. In 2021, he defended his PhD thesis on the effects of nerve growth factor and immune peptides on brain tumor cells, and in 2022-2023, he completed a postdoctoral fellowship at Ben-Gurion University, Israel 🇮🇱.

 

Professional Profile 

Education 🎓

Dr. Chernov holds a PhD with expertise in neurobiology, focusing on brain tumors and chemotherapy. He has a solid foundation in biochemistry, serving as an assistant professor at Saint Petersburg State Pediatric Medical University 🎓.

Work Experience 🏢

Dr. Chernov’s extensive research includes working as a senior researcher at multiple prestigious institutions in Russia, including the D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology. He has also been involved in numerous consultancy and industry projects across nine different sectors.

Awards and Honors 🏆

Dr. Chernov has earned recognition for his exceptional work in brain tumor research, including the nomination for the Best Researcher Award for his article on glioblastoma sensitivity to antimicrobial peptides.

👨‍🏫 Teaching & Memberships🌍

Dr. Chernov is a dedicated educator, currently teaching biochemistry at Saint Petersburg State Pediatric Medical University. He is a member of the Belarusian Society of Physiologists, contributing to his international scientific community .

Research Focus 🔍

His main research areas include glioblastoma, nerve growth factors, chemotherapy, and antimicrobial peptides such as LL-37 and PG-1 🧠. Dr. Chernov’s groundbreaking work has shown how these peptides, in combination with chemotherapy drugs, can predict overall survival in patients with glioblastoma. His research has also demonstrated the effects of these combinations on the inhibition of glioma cell clonogenicity and migration.

Publications : 

 

  • “Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors”
    • Medicinal Chemistry, 2012
  • “Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier”
    • Pharmaceutics, 2011
  • “Biological activity of silver-doped DLC films”
    • Diamond and Related Materials, 2009
  • “Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome”
    • Frontiers in Genetics, 2020
  • “Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients”
    • Frontiers in Immunology, 2021
  • “The phenomenon of multidrug resistance in glioblastomas”
    • Hematology/Oncology and Stem Cell Therapy, 2021
  • “Genetic risk factors for the development of COVID-19 coronavirus infection”
    • Russian Journal of Genetics, 2021
  • “Pharmacogenetic Study of the Impact of ABCB1 Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients”
    • Pharmaceutics, 2022
  • “Pathophysiological mechanisms of autism in children”
    • Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova, 2020
  • “Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration”
    • Molecules, 2022